Lipovast (Atorvastatin)

Atorvastatin blocks the enzyme HMG‑CoA reductase, which is essential for cholesterol synthesis in the liver. By reducing cholesterol production, liver cells increase the number of LDL receptors, enhancing removal of LDL particles from the bloodstream and thereby lowering circulating cholesterol levels.

The dose of Lipovast is individualized by the prescribing clinician based on the patient’s cholesterol levels, cardiovascular risk, and tolerance. The prescriber determines the appropriate strength and dosing schedule, which may be adjusted over time according to therapeutic response and safety monitoring.

Lipovast is classified as pregnancy category X, meaning it is contraindicated during pregnancy because of potential fetal harm. It is also not recommended for breastfeeding mothers, as atorvastatin can be excreted in breast milk and may affect the infant.

To order Lipovast, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lipovast (atorvastatin) is a high‑potency statin with a long half‑life, offering strong LDL‑cholesterol reduction at relatively low doses. Compared with older statins such as simvastatin, atorvastatin often achieves greater lipid lowering and has a well‑characterized safety profile, though individual response and tolerability may vary.

Lipovast tablets should be stored at ambient temperature, preferably below 25 °C. Keep the medication in its original container, protect it from moisture and direct sunlight, and ensure the packaging remains tightly closed until use.

Lipovast is taken orally as a whole tablet, with or without food. Swallow the tablet whole with a glass of water; do not crush, chew, or split the tablet unless specifically instructed by a healthcare professional.

The most serious adverse reactions include rhabdomyolysis (severe muscle breakdown), acute liver injury, and severe allergic responses such as angioedema. Patients should promptly report unexplained muscle pain, dark urine, jaundice, or signs of an allergic reaction to their healthcare provider.

Lipovast should not be used by individuals who are pregnant, have active liver disease, have a known hypersensitivity to atorvastatin or any excipients, or are taking contraindicated medications such as strong CYP3A4 inhibitors. Clinicians should also exercise caution in patients with severe renal impairment.